Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
1.030
+0.030 (3.00%)
Jan 2, 2025, 3:49 PM EST - Market open
Immunic Market Cap
Immunic has a market cap or net worth of $92.78 million as of January 2, 2025. Its market cap has increased by 37.05% in one year.
Market Cap
92.78M
Enterprise Value
35.51M
1-Year Change
37.05%
Ranking
Category
Stock Price
$1.03
Market Cap Chart
Since April 17, 2014, Immunic's market cap has decreased from $253.40M to $92.78M, a decrease of -63.39%. That is a compound annual growth rate of -8.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2024 | 90.10M | 33.09% |
| Dec 29, 2023 | 67.70M | 23.09% |
| Dec 30, 2022 | 55.00M | -78.11% |
| Dec 31, 2021 | 251.20M | -20.71% |
| Dec 31, 2020 | 316.80M | 222.94% |
| Dec 31, 2019 | 98.10M | 1,141.77% |
| Dec 31, 2018 | 7.90M | -96.85% |
| Dec 29, 2017 | 251.10M | 80.13% |
| Dec 30, 2016 | 139.40M | -60.23% |
| Dec 31, 2015 | 350.50M | -41.04% |
| Dec 31, 2014 | 594.50M | 134.61% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 695.13B |
| UnitedHealth Group | 465.54B |
| Novo Nordisk | 384.34B |
| Johnson & Johnson | 348.19B |
| AbbVie | 314.02B |
| Merck & Co. | 251.65B |
| AstraZeneca | 203.17B |
| Thermo Fisher Scientific | 198.99B |